Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Amortization of Deferred Charges (2019 - 2025)

Historic Amortization of Deferred Charges for Selectis Health (GBCS) over the last 6 years, with Q3 2025 value amounting to $4184.0.

  • Selectis Health's Amortization of Deferred Charges rose 1086.38% to $4184.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $16328.0, marking a year-over-year decrease of 8431.7%. This contributed to the annual value of $103432.0 for FY2024, which is 7025.96% down from last year.
  • Latest data reveals that Selectis Health reported Amortization of Deferred Charges of $4184.0 as of Q3 2025, which was up 1086.38% from $4184.0 recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Amortization of Deferred Charges ranged from a high of $197290.0 in Q2 2023 and a low of $3774.0 during Q3 2024
  • For the 4-year period, Selectis Health's Amortization of Deferred Charges averaged around $44361.3, with its median value being $25304.5 (2021).
  • In the last 5 years, Selectis Health's Amortization of Deferred Charges surged by 8923.7% in 2021 and then plummeted by 9476.26% in 2025.
  • Over the past 4 years, Selectis Health's Amortization of Deferred Charges (Quarter) stood at $87700.0 in 2021, then tumbled by 94.92% to $4457.0 in 2023, then fell by 15.28% to $3776.0 in 2024, then increased by 10.81% to $4184.0 in 2025.
  • Its Amortization of Deferred Charges was $4184.0 in Q3 2025, compared to $4184.0 in Q2 2025 and $4184.0 in Q1 2025.